JD Health International (STU:8ZN) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:8ZN JD Health International Inc STU:8ZN
84 GF Score
Price €4.11
GF Value €6.38
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is JD Health International FFO?

FFO (Funds from operations) only applies to REITs.

STU:8ZN
84GF Score
JD Health International Inc STU:8ZN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is JD Health International (STU:8ZN) Overvalued in 2026?

Based on GuruFocus' analysis, JD Health International stock appears to be undervalued. The current stock price of €4.11 is trading 35.6% below its estimated GF Value™ of €6.38. GuruFocus considers JD Health International to be Significantly Undervalued.

Key valuation signals for STU:8ZN:

  • FFO:
  • GF Value™: €6.38 vs. price of €4.11 (35.6% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the STU:8ZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JD Health International Business Description

Address No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
84GF Score

Get the complete analysis for STU:8ZN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.11
Price
€6.38
GF Value